Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis

Introduction Chronic inflammation is increasingly recognised as a major contributor to disease, disability and ultimately death, but measuring the levels of chronic inflammation remains non-canonised, making it difficult to relate chronic inflammation and mortality. Soluble urokinase plasminogen act...

Full description

Bibliographic Details
Published in:BMJ Open
Main Authors: Thomas Kallemose, Jens Emil Vang Petersen, Karen D Barton, Avshalom Caspi, Line Jee Hartmann Rasmussen
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Online Access:https://bmjopen.bmj.com/content/10/7/e036125.full